Delivery Order 75N95024D00022-75N95024F00001

On September 18, 2024, the National Center for Advancing Translational Sciences (NCATS) awarded a $512,266 delivery order to IIT Research Institute (IITRI), a non-profit contract research organization and subsidiary of the Illinois Institute of Technology. The contract, which carries no set-aside designation, supports preclinical development of NCGC72, a first-in-class small molecule CD206 agonist candidate intended for treatment of immunologically cold solid organ cancers. Work will be...

The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm fixed price purchase order to The Society of Toxicology (SOT), a non-profit organization, for the "THE SOCIETY OF TOXICOLOGY/FDA COLLOQUIA ON EMERGING TOXICOLOGICAL SCIENCE CHALLENGES IN FOOD AND INGREDIENT SAFETY" with a potential value of $125,629.00. The contract, which does not have a set-aside designation, is for the provision of scientific engagement, education, and workforce...

The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $503,901 Delivery Order to Sri International under the Pharmacology and Toxicology for Therapeutics Program Indefinite Delivery Indefinite Quantity master contract. Sri International will provide Follow-On Studies - Ind-Enabling GLP Toxicology from its West Menlo Park, California location between September 2022 and September 2024. Charles River...

This is a Cost Plus Fixed Fee delivery order awarded to SRI International, a non-profit research and development institute, by the National Institute on Drug Abuse (NIDA) under the Pharmacology and Toxicology for Therapeutics Program (PTTP) Indefinite Delivery Indefinite Quantity (IDIQ) contract. The contract has a ceiling value of $2,343,369.90 and a period of performance ending on March 31, 2022. SRI International will provide pharmacology and toxicology services for the PTTP. The contract...

The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $268,799.00 delivery order contract to Sri International for non-clinical safety assessment of ORC-13661 to support aminoglycoside induced hearing loss indication. Sri International will perform the work as the prime contractor in West Menlo Park, California from September 14, 2022 through November 13, 2023. Bioivt, LLC will serve as a subcontractor providing a...

Sri International has been awarded Task Order 75N95020F00002 under the National Institute on Drug Abuse (NIDA) Indefinite Delivery/Indefinite Quantity (IDIQ) contract HHSN271201800019I to conduct Good Laboratory Practice (GLP) interaction safety studies in rats and dogs. This task order, valued at $1.2M, supports NIDA's broader program of toxicological evaluations of potential medications and was awarded on September 14, 2020, with a completion date of September 13, 2022. The work will be...

This firm fixed-price delivery order contract was awarded by the Food and Drug Administration (FDA) to Integrated Laboratory Systems, LLC (ILS), a for-profit research and testing services company. The contract, valued at $88,156.00, is for a pilot study on the in vivo genetic toxicity of the chemical NNK (nicotine-derived nitrosamine ketone) in mice using the intraperitoneal route of administration. This contract is part of a larger $7.8 million indefinite delivery contract (IDC) awarded by...

Sri International has been awarded a cost-plus-fixed-fee delivery order valued at $571,190 by the National Institute on Drug Abuse (NIDA), a component of the Department of Health and Human Services (HHS), to conduct Task Order 01 for Cocaine Interaction Safety Studies in Rats under the Toxicological Evaluations of Potential Medications IDIQ. The ordering period is from September 12, 2023 through September 11, 2024. The place of performance is West Menlo Park, California. No set-aside designation...

Sri International has been awarded a delivery order against the PREVENT Preclinical Drug Development Program (PREVENT) multiple award contract vehicle to provide orientation and kick-off meeting services for the PREVENT contract. This $4,863 cost-plus-fixed-fee order was issued by the National Cancer Institute, a component of the Department of Health and Human Services, and will be performed in West Menlo Park, California with a period of performance from January 25, 2019 through February 24,...

This is a $1,010.00 firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to the IIT Research Institute (IITRI), a non-profit contract research organization. The contract is for a "Kick Off Meeting, Preclinical Pharmacokinetic & Pharmacology Evaluations of Agents Being Developed for Cancer Patients" with a performance period from July 1, 2016 to September 30, 2016. This work is being performed under NCI's Pharmacokinetic and Pharmacology Evaluations for...